PharmaMar Banner Image


  • Ticker
  • Industry Biotechnology More
  • Sector Healthcare More
PharmaMar Logo Image
  • 201-500 Employees
  • Based in Madrid, Spain
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissueMore sarcomas and for ovarian cancer; and Aplidin for treating multiple myeloma. The company also develops clinical-stage programs, including Lurbinectedin, PM184, and PM14. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain.
4.8 / 5.0 (88)

PharmaMar reports have an aggregate usefulness score of 4.8 based on 88 reviews.


Most Recent Responsibility Report

MOST RECENT 2023 Annual Corporate Governance Report

PharmaMar does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Archived Responsibility Reports

Our service enables potential investors to review the most recent and archived PharmaMar Sustainability Report, PharmaMar Corporate Social Responsibility Report, PharmaMar CSR Report, PharmaMar Corporate Responsibility, PharmaMar CR Report, PharmaMar Citizenship Report, PharmaMar ESG Report, and PharmaMar Environmental Report online.
PharmaMar Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!